Mark Collins $MarkCollins

Having been raised in Cupertino, CA, Mark upped and joined the East Cost biotech scene at the turn of the last decade. He provides research and analysis in the small cap sector, and is an active investor in development stage healthcare. Mark is currently the Biotechnology and Healthcare editor at Market Exclusive.